Key findings from these early studies included: Long half-life (~200300 hours): Tesofensine has an exceptionally long elimination half-life, allowing for once-daily oral dosing and stable plasma concentrations Dose-proportional pharmacokinetics: Blood levels increased predictably with dose across the 0.125 mg to 1.0 mg range Acceptable tolerability: The most common side effects were dry mouth, insomnia, nausea, and constipation consistent with its monoaminergic mechanism Cardiovascular signal: Dose-dependent increases in heart rate (typically 510 bpm) were observed, along with modest blood pressure changes at higher doses The Parkinson's disease Phase I/II trials were particularly informative
Monitoring and Dose Adjustment Without a Gallbladder Patients without a gallbladder may experience earlier or more pronounced gastrointestinal side effects from semaglutide, such as nausea, constipation, or diarrhea
doi:10.1155/2012/736837 Kumar P, Liu C, Suliburk J, Hsu JW, Muthupillai R, Jahoor F, Minard CG, Taffet GE, Sekhar RV
NO gluten
Alcohol can potentially lower blood sugar levels, increasing the risk of hypoglycemia
Who is the manufacturer of Cartin injection
